The main European indices returned to positive territory after the significant losses they recorded yesterday, thus completing after some time three upward sessions in the last four.
In particular, the pan-European Stoxx 600 index closed at 434.8 points with an increase of 0.8%, with most of their sectors moving upwards.
In the sub-boards, the German DAX rose 0.63% to 14,008 points, the French CAC 40 strengthened by 0.73% to 6,298 points, as well as the British FTSE 100 which finished at 7,524 points with + 0.54%.
The picture was even better in the region, where the Italian FTSE MIB and the Spanish IBEX 35 both strengthened by more than 1.5%, closing the first at 24,250 points and the second at 8,764.
The data on the German economy, which avoided the contraction in the first quarter of 2022, showed a positive effect on the investment mood, with the country’s GDP growing by 0.2% compared to the previous quarter, receiving support from investments. .
On an annual basis, German GDP ran at a rate of 3.8% on an adjusted basis.
In terms of individual shares, the Austrian power company Verbund and the British e-commerce chain The Hut Group were at the top of the Stoxx 600, with an increase of about 9.5% each.
Meanwhile, the German Eventim stock plunged 6% after the underperform rating given to it by BNP Paribas, predicting downward trends in its revenues.
Investors are expected to turn their attention to the minutes of the latest meeting of the US Federal Reserve, which will be released later today, seeking more information on the US economy outlook and the central bank in the coming months.
Source: Capital
I am Sophia william, author of World Stock Market. I have a degree in journalism from the University of Missouri and I have worked as a reporter for several news websites. I have a passion for writing and informing people about the latest news and events happening in the world. I strive to be accurate and unbiased in my reporting, and I hope to provide readers with valuable information that they can use to make informed decisions.